Cover Image

EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC

Show other versions (1)

Solvay pharma expands its product portfolio, by launching alfa normix (rifaximin) for the treatment of the gastroenteric infections. Alfa normix is a non-systemic broad-spectrum antibiotic to treat acute gastroenteric infections and is prescribed for the travelers suffering from diarrhea, the overgr...

Full description

Saved in:

Bibliographic Details
Main Author:	article editorial (Author)
Format:	Book
Published:	Union of pediatricians of Russia, 2008-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
by: article editorial
Published: (2008)

RIFAXIMIN TO TREAT OF GASTROINTESTINAL INFECTIONS
by: article editorial
Published: (2008)

RIFAXIMIN TO TREAT OF GASTROINTESTINAL INFECTIONS
by: article editorial
Published: (2008)

Use of Rifaximin in Irritable Bowel Syndrome Treatment
by: Hubert Wróblewski, et al.
Published: (2021)

Diverticular Disease and Rifaximin: An Evidence-Based Review
by: Anna Piccin, et al.
Published: (2023)

Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers
by: Blandizzi C, et al.
Published: (2014)

Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
by: Wang Z, et al.
Published: (2018)

The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea
by: Hoonmo L Koo, et al.
Published: (2009)

COMPLEX TREATMENT OF HELICOBACTER PYLORI INFECTION WITH RIFAXIMIN IN CHILDREN
by: A.A. Nizhevich, et al.
Published: (2009)

Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication
by: Hyun Soo Kim, et al.
Published: (2020)

COMPLEX TREATMENT OF HELICOBACTER PYLORI INFECTION WITH RIFAXIMIN IN CHILDREN
by: A.A. Nizhevich, et al.
Published: (2009)

Highly Polymorphic Materials and Dissolution Behaviour: The Peculiar Case of Rifaximin
by: Annalisa Bianchera, et al.
Published: (2022)

Clinical Pharmacology in Health Care, Teaching and Research
by: Article Editorial
Published: (2020)

Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier
by: Torre A, et al.
Published: (2023)

Rifaximin plus cefotaxime versus cefotaxime alone in treatment of spontaneous bacterial peritonitis in patients with cirrhosis
by: Asmaa N Mohammad, et al.
Published: (2018)

Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy
by: Xianghui Han, et al.
Published: (2021)

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
by: Jie Jian, et al.
Published: (2022)

Validation of the HPLC-PDA method for detection of eluxadoline and rifaximin in rat plasma and application in a pharmacokinetic study
by: Vijendar Reddy Karla, et al.
Published: (2022)

Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers' diarrhea: a systematic review and network meta-analysis
by: Hao Fan, et al.
Published: (2024)

Rifaximin plus norfloxacin versus norfloxacin alone in primary prophylaxis of spontaneous bacterial peritonitis in patients with variceal bleeding
by: Ahmed A Ghafar, et al.
Published: (2019)

Antibiotics for the treatment of COVID‐19
by: article Editorial
Published: (2022)

Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification
by: Ding P, et al.
Published: (2021)

Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
by: Huaizhu Guo, et al.
Published: (2023)

Pediatricians on guard of children's health: empiric therapy, but not antibiotics
by: article Editorial
Published: (2023)

Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
by: Kosuke Kaji, et al.
Published: (2020)

Clinical manifestation of enteritis in children
by: Joon Yeol Bae, et al.
Published: (2018)

WHO HAS WARNED ABOUT GROWING BACTERIAL ANTIBIOTIC RESISTANCE
by: article Editorial
Published: (2024)

Effect of selective gastric residual monitoring on enteral intake in preterm infants
by: Serena Elia, et al.
Published: (2022)

Severe Sunburn-Like Adverse Cutaneous Drug Reaction in a Patient on Treatment with Rifaximin: A Rare Case of Acute Phototoxic Drug Reaction
by: Vikram Mahajan, et al.
Published: (2022)

A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin
by: Xuezhi Zhuo, et al.
Published: (2022)

DORIPENEM - modern carbapenem antibiotic for the effective, safe and economical treatment of nosocomial infections
by: Editorial Article
Published: (2020)

DORIPENEM - modern carbapenem antibiotic for the effective, safe and economical treatment of nosocomial infections
by: Editorial Article
Published: (2018)

Clinical experimentation with aerosol antibiotics: current and future methods of administration
by: Zarogoulidis P, et al.
Published: (2013)

Experimental pharmacology in precision medicine
by: Alicja Urbaniak, et al.
Published: (2023)

Experimental Pharmacological Management of Psoriasis
by: Campione E, et al.
Published: (2021)

Clinical experimentation with aerosol antibiotics: current and future methods of administration [Corrigendum]
by: Zarogoulidis P, et al.
Published: (2014)

Antibiotic Treatment Induces Long-Lasting Effects on Gut Microbiota and the Enteric Nervous System in Mice
by: Giulia Bernabè, et al.
Published: (2023)

Capabilities of atopic dermatitis systemic therapy with selective immunosuppressors: resolution of the experts workshop of dermatology profile
by: article Editorial
Published: (2022)

Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings
by: Alshehri FS
Published: (2023)

Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis
by: Xinghua Xiao, et al.
Published: (2022)